forum

PARABDRUGS Share Price Discussion

Parabolic Drugs Ltd.
Sector: Pharmaceuticals and health care
... Read more
PARABDRUGS Share Price *
0 +0 (0%)
* (quote may be delayed)

PARABDRUGS Discussion Forum

hourglass_empty
No posts yet.
This service may be new or inactive. Please check back later.
  • PARABDRUGS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization46.11
    Enterprise Value1,029.33
    Price to Earnings3.53
    Price to Book Value0.18
    Return on Capital Employed-0.41
    Return on Equity0.07
    Face Value10
    Dividend YieldNA
  • PARABDRUGS Share Price - Technicals

    keyboard_arrow_down
    PARABDRUGS - 52 Week High₹4.1
    PARABDRUGS - 52 Week Low₹3.4
  • PARABDRUGS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 213.63.73.453.65
    Sep 193.753.753.553.6
    Sep 183.73.853.553.65
    Sep 173.73.853.553.7
    Sep 143.73.73.43.7
  • PARABDRUGS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹3.72
    30 Day Moving Average₹3.7
    50 Day Moving Average₹3.58
    100 Day Moving Average₹3.58
    200 Day Moving Average₹3.58
  • PARABDRUGS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue7173.72-0.04
    Operating Profit-16-45.72-0.65
    Profit Before Tax-55-105.02-0.48
    Net Income-57-108.07-0.47
  • PARABDRUGS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds-872-815.330.07
    Total Liabilities1,2911,308.71-0.01
    Total Assets419493.38-0.15
  • PARABDRUGS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity31.650.82
    Cash from Investing Activity10.51
    Cash from Financing Activity-4-2.190.83
    Net Cash FlowNA-0.03-1
  • PARABDRUGS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.14-0.22
    Return on Equity0.070.13
    Return on Capital Employed-0.41-0.58
  • PARABDRUGS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.69
    3 Year CAGR Growth in Operating Profit0.8
    3 Year CAGR Growth in EBIDTA0.86
    3 Year CAGR Growth in Net Income0.85
    3 Yr CAGR Growth - Diluted EPS0.85
  • PARABDRUGS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.91
    5 Year CAGR Growth in Operating Profit0.78
    5 Year CAGR Growth in EBIDTA0.84
    5 Year CAGR Growth in Net Income0.59
    3 Yr CAGR Growth - Diluted EPS0.59
  • PARABDRUGS - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.